These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6504211)

  • 1. Assessment of lethal and cytostatic effects of alkylnitrosoureas on the cells of experimental tumors.
    Emanuel NM; Ostrovskaya LA; Krutova TV; Konradov AA
    Neoplasma; 1984; 31(5):529-38. PubMed ID: 6504211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of nitrosomethylurea derivatives in the combined chemotherapy of experimental tumors].
    Krutova TV; Ostrovskaia LA
    Eksp Onkol; 1986; 8(5):47-50. PubMed ID: 3780511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.
    Hill RP; Stanley JA
    Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of the immunogenic properties of a radiation-induced mouse lymphoma following treatment with antitumor drugs.
    Bonmassar E; Testorelli C; Franco P; Goldin A; Cudkowicz G
    Cancer Res; 1975 Aug; 35(8):1957-62. PubMed ID: 1149019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An experimental model comparing the antineoplastic and the immunosuppressive effects of some cytostatics.
    Ghyka G; Haraga L
    Arch Roum Pathol Exp Microbiol; 1989; 48(1):33-45. PubMed ID: 2802968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)- hydrazines.
    Shyam K; Penketh PG; Loomis RH; Rose WC; Sartorelli AC
    J Med Chem; 1996 Feb; 39(3):796-801. PubMed ID: 8576923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of anticancer agents by amphotericin B.
    Medoff G; Valeriote F; Dieckman J
    J Natl Cancer Inst; 1981 Jul; 67(1):131-5. PubMed ID: 6942183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor activity of a combination of dimethylnitrosourea and a carbohydrate derivative of nitrosourea (ADEKO) with cyclophosphamide in an experiment].
    Krutova TV; Kondradov AA; Ostrovskaia LA
    Izv Akad Nauk SSSR Biol; 1984; (3):439-45. PubMed ID: 6747090
    [No Abstract]   [Full Text] [Related]  

  • 9. Lethal toxicity of cyclophosphamide depends on the tumor stage. Studies on the syngeneic adenocarcinoma EO 771 in C57bl/6j mice.
    Bassukas ID; Maurer-Schultze B
    Anticancer Res; 1993; 13(3):827-34. PubMed ID: 8317919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of modulators and cytostatics on catabolism of I-125 desoxyuridine in tumors (express-method of antineoplastic modulator screening)].
    Obernikhin SS; Fuks BB
    Biull Eksp Biol Med; 1992 Jul; 114(7):68-70. PubMed ID: 1421315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice].
    Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN
    Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mathematical model to study the effects of drugs administration on tumor growth dynamics.
    Magni P; Simeoni M; Poggesi I; Rocchetti M; De Nicolao G
    Math Biosci; 2006 Apr; 200(2):127-51. PubMed ID: 16516246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.
    Stephens TC; Peacock JH
    Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model.
    Sigounas G; Sallah S; Sigounas VY
    Cancer Lett; 2004 Oct; 214(2):171-9. PubMed ID: 15363543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of biological response modifiers against transplantable mouse tumors of spontaneous origin. I. Characterization of biological properties of tumor lines and preliminary data on response to cytostatic drugs and biomodulators.
    Fiszer-Maliszewska L; Mordarski M; Madej JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):1-9. PubMed ID: 8239902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of blood letting on the sensitivity of the CFU C57BL/C3H mice to various antineoplastic agents].
    Massa G; Saviane A; Bogliolo G; Mitra G; Pannacciulli I
    Boll Soc Ital Biol Sper; 1977 Aug; 53(15):1252-6. PubMed ID: 603671
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relationship of the antitumor action of cyclophosphamide and prednisolone to the sequence of their administration and to the intervals between administrations in methylcholanthrene carcinogenesis in mice].
    Ladnova GG; Gavrilova TN
    Farmakol Toksikol; 1979; 42(6):666-70. PubMed ID: 499478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An experimental model for predicting the synergism of hyperthermia with cytostatics.
    Andrysek O; Bláhová E; Gregora V; Rezný Z
    Neoplasma; 1985; 32(1):93-101. PubMed ID: 3982565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.